Search Results - "Miller, Vicki E"

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial by Keech, Cheryl, Miller, Vicki E, Rizzardi, Barbara, Hoyle, Christopher, Pryor, Melinda J, Ferrand, Jonathan, Solovay, Ken, Thalen, Marcel, Noviello, Stephanie, Goldstein, Peter, Gorringe, Andrew, Cavell, Breeze, He, Qiushui, Barkoff, Alex-Mikael, Rubin, Keith, Locht, Camille

“…Bordetella pertussis epidemics persist as transmission remains unabated despite high acellular pertussis vaccination rates. BPZE1, a live attenuated intranasal…”
Get full text

Long-term neurological outcomes in West Nile virus-infected patients: an observational study by Weatherhead, Jill E, Miller, Vicki E, Garcia, Melissa N, Hasbun, Rodrigo, Salazar, Lucrecia, Dimachkie, Mazen M, Murray, Kristy O

“…The Houston West Nile Cohort (HWNC) was founded in 2002 when West Nile virus (WNV) reached Houston, TX. The long-term outcomes following WNV infection are…”
Get full text

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial by El Sahly, Hana M, Baden, Lindsey R, Essink, Brandon, Montefiori, David, McDermont, Adrian, Rupp, Richard, Lewis, Michael, Swaminathan, Shobha, Griffin, Carl, Fragoso, Veronica, Miller, Vicki E, Girard, Bethany, Paila, Yamuna D, Deng, Weiping, Tomassini, Joanne E, Paris, Robert, Schödel, Florian, Das, Rituparna, August, Allison, Leav, Brett, Miller, Jacqueline M, Zhou, Honghong, Pajon, Rolando

“…Messenger RNA (mRNA)-1273 vaccine demonstrated 93.2% efficacy against coronavirus disease 2019 (COVID-19) in the Coronavirus Efficacy (COVE) trial. The humoral…”
Get full text

Increased salivary exoglycosidase activity during critical illness by Quinn, M O, Miller, V E, Dal Nogare, A R

“…Exoglycosidases remove peripheral monosaccharides from oligosaccharides and hence are capable of altering respiratory epithelial cell surface carbohydrates. We…”
Get more information